Growing community of inventors

Saitama, Japan

Shizuo Kuriyama

Average Co-Inventor Count = 3.08

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 24

Shizuo KuriyamaNoriyasu Hirose (4 patents)Shizuo KuriyamaShigeru Souda (2 patents)Shizuo KuriyamaKazutoshi Miyake (2 patents)Shizuo KuriyamaYasuhiro Akiyama (2 patents)Shizuo KuriyamaHidetoshi Kawashima (2 patents)Shizuo KuriyamaKazuyasu Usuki (2 patents)Shizuo KuriyamaMikio Saitoh (2 patents)Shizuo KuriyamaKiyomi Yamatsu (1 patent)Shizuo KuriyamaNaoko Nagaoka (1 patent)Shizuo KuriyamaNaoko Sakabe (1 patent)Shizuo KuriyamaAkifumi Kitahara (1 patent)Shizuo KuriyamaTakeshi Uzuo (1 patent)Shizuo KuriyamaShizuo Kuriyama (6 patents)Noriyasu HiroseNoriyasu Hirose (11 patents)Shigeru SoudaShigeru Souda (43 patents)Kazutoshi MiyakeKazutoshi Miyake (24 patents)Yasuhiro AkiyamaYasuhiro Akiyama (21 patents)Hidetoshi KawashimaHidetoshi Kawashima (7 patents)Kazuyasu UsukiKazuyasu Usuki (2 patents)Mikio SaitohMikio Saitoh (2 patents)Kiyomi YamatsuKiyomi Yamatsu (21 patents)Naoko NagaokaNaoko Nagaoka (5 patents)Naoko SakabeNaoko Sakabe (1 patent)Akifumi KitaharaAkifumi Kitahara (1 patent)Takeshi UzuoTakeshi Uzuo (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Eisai Company, Limited (5 from 677 patents)

2. Mitsubishi Chemical Industries Limited (2 from 614 patents)

3. Eisai Ci., Ltd. (1 from 1 patent)


6 patents:

1. 4576966 - Treatment of mental symptoms caused by organic disorder in brain

2. 4567180 - Carboximide derivative and medicines containing same

3. 4514395 - Phenothiazine derivatives and anti-psychotic drugs containing the same

4. 4507322 - Pharmaceutical composition useful for improvement and/or treatment of

5. 4479954 - Piperazine substituted carboxamide derivatives, compositions and method

6. 4139632 - Psychotropic

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…